Clinical Trial Update: Open-label Trial of IVIG in Children With PANS [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial of intravenous immunoglobulin in children with Pediatric Acute-Onset Neuropsychiatric Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute-onset Neuropsychiatric Syndrome

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Göteborg University | Conditions: PANS Pediatric Acute-Onset Neuropsychiatric Syndrome | Phase 2 | Status: COMPLETED